Clinical sensitivity and specificity of meconium fatty acid ethyl ester, ethyl glucuronide, and ethyl sulfate for detecting maternal drinking during pregnancy

Clinical Chemistry

Volumn 61, Issue 3, 2015, Pages 523-532

  Himes, Sarah K ^a   Dukes, Kimberly A ^b   Tripp, Tara ^b   Petersen, Julie M ^b   Raffo, Cheri ^b   Burd, Larry ^c   Odendaal, Hein ^d   Elliott, Amy J ^e   Hereld, Dale ^f   Signore, Caroline ^g   Willinger, Marian ^g   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b DM STAT Inc   (United States)

^c UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d UNIVERSITY OF STELLENBOSCH   (South Africa)

^e SANFORD RESEARCH   (United States)

^f NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ETHYL ARACHIDONATE; ETHYL GLUCURONIDE; ETHYL LAURATE; ETHYL LINOLENATE; ETHYL MYRISTATE; ETHYL PALMITOLEATE; ETHYL STEARATE; FATTY ACID ESTER; LAURIC ACID; LINOLEIC ACID ETHYL ESTER; METHYL GROUP; OLEIC ACID ETHYL ESTER; PALMITIC ACID ETHYL ESTER; SULFATE; UNCLASSIFIED DRUG; DIETHYL SULFATE; ESTER; FATTY ACID; GLUCURONIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; EXPOSURE; FEMALE; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BEHAVIOR; MECONIUM; PRENATAL EXPOSURE; SELF CONCEPT; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; THIRD TRIMESTER PREGNANCY; BLOOD; CHEMISTRY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; PREGNANCY;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; ESTERS; FATTY ACIDS; FEMALE; GLUCURONATES; HUMANS; LIMIT OF DETECTION; MECONIUM; PREGNANCY; SENSITIVITY AND SPECIFICITY; SULFURIC ACID ESTERS; TANDEM MASS SPECTROMETRY;

EID: 84923876647     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.233718     Document Type: Article

References (39)

1. Coriale G, Fiorentino D, Di Lauro F, Marchitelli R, Scalese B, Fiore M, et al. Fetal alcohol spectrum disorder (FASD): neurobehavioral profile, indications for diagnosis and treatment. Riv Psichiatr 2013;48:359-69.
2. Mattson SN, Roesch SC, Glass L, Deweese BN, Coles CD, Kable JA, et al. Further development of a neurobehavioral profile of fetal alcohol spectrum disorders. Alcohol Clin Exp Res 2013;37:517-28.
3. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. NSDUH Ser. H-46, HHS Publ. No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
4. Iyasu S, Randall LL, Welty TK, Hsia J, Kinney HC, Mandell F, et al. Risk factors for sudden infant death syndrome among Northern Plains Indians. JAMA 2002; 288:2717-23.
5. May PA, Gossage JP, Brooke LE, Snell CL, Marais AS, Hendricks LS, et al. Maternal risk factors for fetal alcohol syndrome in the Western cape province of South Africa: a population-based study.AmJ Public Health 2005;95:1190-9.
6. Peterson J, Kirchner HL, Xue W, Minnes S, Singer LT, Bearer CF. Fatty acid ethyl esters in meconium are associated with poorer neurodevelopmental outcomes to two years of age. J Pediatr 2008;152:788-92.
7. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr 2004;25:228-38.
8. Bearer CF, Santiago LM, O'Riordan MA, Buck K, Lee SC, Singer LT. Fatty acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J Pediatr 2005;146:824-30.
9. Chan D, Bar-Oz B, Pellerin B, Paciorek C, Klein J, Kapur B, et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit 2003;25:271-8.
10. Chan D, Klein J, Karaskov T, Koren G. Fetal exposure to alcohol as evidenced by fatty acid ethyl esters in meconium in the absence of maternal drinking history in pregnancy. Ther Drug Monit 2004;26:474-81.
11. Bakdash A, Burger P, Goecke TW, Fasching PA, Reulbach U, Bleich S, et al. Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study. Anal Bioanal Chem 2010;396:2469-77.
12. Morini L, Groppi A, Marchei E, Vagnarelli F, Garcia Algar O, Zuccaro P, Pichini S. Population baseline of meconium ethyl glucuronide and ethyl sulfate concentrations in newborns of nondrinking women in 2 Mediterranean cohorts. Ther Drug Monit 2010;25:271-8.
13. Morini L, Marchei E, Pellegrini M, Groppi A, Stramesi C, Vagnarelli F, et al. Liquid chromatography with tandem mass spectrometric detection for the measurement of ethyl glucuronide and ethyl sulfate in meconium: new biomarkers of gestational ethanol exposure? Ther Drug Monit 2008;30:725-32.
14. Morini L, Marchei E, Vagnarelli F, Garcia Algar O, Groppi A, Mastrobattista L, Pichini S. Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol. Forensic Sci Int 2010;196:74-7.
15. Pichini S, Marchei E, Vagnarelli F, Tarani L, Raimondi F, Maffucci R, et al. Assessment of prenatal exposure to ethanol by meconium analysis: results of an Italian multicenter study. Alcohol Clin Exp Res 2012;36:417-24.
16. Pichini S, Morini L, Pacifici R, Tuyay J, Rodrigues W, Solimini R, et al. Development of a new immunoassay for the detection of ethyl glucuronide (EtG) in meconium: validation with authentic specimens analyzed using LC-MS/MS. Preliminary results. Clin Chem Lab Med 2014;52:1179-85.
17. Pichini S, Pellegrini M, Gareri J, Koren G, Garcia-Algar O, Vall O, et al. Liquid chromatography-tandem mass spectrometry for fatty acid ethyl esters in meconium: assessment of prenatal exposure to alcohol in two European cohorts. J Pharm Biomed Anal 2008;48:927-33.
18. Pichini S, Morini L, Marchei E, Palmi I, Rotolo MC, Vagnarelli F, et al. Ethylglucuronide and ethylsulfate in meconium to assess gestational ethanol exposure: preliminary results in two Mediterranean cohorts. Can J Clin Pharmacol 2009;16:e370-5.
19. Laposata M. Fatty acid ethyl esters: nonoxidative ethanol metabolites with emerging biological and clinical significance. Lipids 1999;34 Suppl:S281-5.
20. Chan D, Knie B, Boskovic R, Koren G. Placental handling of fatty acid ethyl esters: perfusion and subcellular studies. J Pharmacol Exp Ther 2004;310:75-82.
21. Hutson JR, Rao C, Fulga N, Aleksa K, Koren G. An improved method for rapidly quantifying fatty acid ethyl esters in meconium suitable for prenatal alcohol screening. Alcohol 2011;45:193-9.
22. Joya X, Friguls B, Ortigosa S, Papaseit E, Martinez SE, Manich A, et al. Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal 2012;69:209-22.
23. Coughtrie MW, Burchell B, Leakey JE, Hume R. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 1988;34:729-35.
24. Matlow JN, Lubetsky A, Aleksa K, Berger H, Koren G. The transfer of ethyl glucuronide across the dually perfused human placenta. Placenta 2013;34:369-73.
25. Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol 2008;82:155-65.
26. Himes SK, Concheiro M, Scheidweiler KB, Huestis MA. Validation of a novel method to identify in utero ethanol exposure: simultaneous meconium extraction of fatty acid ethyl esters, ethyl glucuronide, and ethyl sulfate followed by LC-MS/MS quantification. Anal Bioanal Chem 2014;406:1945-55.
27. Dukes KA, Burd L, Elliott AJ, Fifer WP, Folkerth RD, Hankins GD, et al. The Safe Passage Study: design, methods, recruitment and follow-up approach. Paediatr Perinat Epidemiol 2014;28:455-65.
28. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, eds. Measuring alcohol consumption: psychosocial and biological methods. Totowa, NJ: Humana Press; 1992:41-72.
29. Dawson DA. Methodological issues in measuring alcohol use. Alcohol Res Health 2003;27:18-29.
30. Burd L, Hofer R. Biomarkers for detection of prenatal alcohol exposure: a critical review of fatty acid ethyl esters in meconium. Birth Defects Res A Clin Mol Teratol 2008;82:487-93.
31. Society of Hair Testing. Use of alcohol markers in hair for abstinence assessment: consensus of the Society of Hair Testing. www.soht.org/images/pdf/Use of Alcohol Markers in Hair for Abstinence Assessment 2012.pdf (Accessed April 10, 2014).
32. Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 2012;24:69-71.
33. Goecke TW, Burger P, Fasching PA, Bakdash A, Engel A, Haberle L, et al. Meconium indicators of maternal alcohol abuse during pregnancy and association with patient characteristics. Biomed Res Int 2014;2014:702848.
34. Ekholm O, Strandberg-Larsen K, Christensen K, Gronbaek M. Comparison of assessment methods for selfreported alcohol consumption in health interview surveys. Eur J Clin Nutr 2008;62:286-91.
35. Dahl H, Voltaire Carlsson A, Hillgren K, Helander A. Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence. Alcohol Alcohol 2011;46:278-82.
36. Lande RG, Marin B. A comparison of two alcohol biomarkers in clinical practice: ethyl glucuronide versus ethyl sulfate. J Addict Dis 2013;32:288-92.
37. Al Saabi A, Allorge D, Sauvage FL, Tournel G, Gaulier JM, Marquet P, Picard N. Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse. Drug Metab Dispos 2013;41:568-74.
38. Helander A, Olsson I, Dahl H. Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption. Clin Chem 2007;53:1855-7.
39. Baranowski S, Serr A, Thierauf A, Weinmann W, Grosse Perdekamp M, Wurst FM, Halter CC. In vitro study of bacterial degradation of ethyl glucuronide and ethyl sulphate. Int J Legal Med 2008;122:389-93.